Related Experiment Videos
[Osteoprotegerin (OPG/OCIF) inhibits bone destruction in rheumatoid arthritis models]
1Center for Experimental Medicine, Institute of Medical Science, University of Tokyo.
Abstract:
Recent discovery of factors involved in bone destruction in Rheumatoid Arthritis (RA) identified its molecular mechanism. Osteoclast differentiation factor (ODF, also called receptor activator of NF-kappaB ligand (RANKL) ) that controls osteoclast differentiation and function has a major role in the bone destruction among them. Osteoclastogenesis inhibitory factor (OCIF, also called osteoprotegerin (OPG) ) that is a decoy receptor for ODF/RANKL is a specific inhibitor of bone destruction. OPG/OCIF may be useful for and applicable to the treatment of bone destruction in RA.
Insights
Rheumatoid Arthritis (RA) involves bone destruction regulated by Osteoclast differentiation factor (ODF/RANKL). Osteoclastogenesis inhibitory factor (OCIF/OPG) may treat RA bone loss.
Area of Science:
- Immunology
- Orthopedics
- Molecular Biology
Context:
- Rheumatoid Arthritis (RA) is characterized by significant bone destruction.
- The molecular mechanisms underlying RA-associated bone loss are increasingly understood.
Purpose:
- To elucidate the roles of key molecular factors in Rheumatoid Arthritis bone destruction.
- To identify potential therapeutic targets for mitigating bone loss in RA.
Summary:
- Osteoclast differentiation factor (ODF), also known as receptor activator of NF-kappaB ligand (RANKL), is crucial for osteoclast differentiation and function, driving bone destruction in RA.
- Osteoclastogenesis inhibitory factor (OCIF), or osteoprotegerin (OPG), acts as a decoy receptor for ODF/RANKL, specifically inhibiting bone destruction.
- The balance between ODF/RANKL and OCIF/OPG is critical in regulating bone metabolism in RA.
Impact:
- Understanding the ODF/RANKL and OCIF/OPG pathway provides insights into RA pathogenesis.
- OCIF/OPG presents a potential therapeutic strategy for treating bone destruction in Rheumatoid Arthritis patients.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...